Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2009
11/03/2009CA2306275C Universal mechanical testing device
11/03/2009CA2257940C Method of explosives detection
11/03/2009CA2252648C Non-invasive enzyme screen for tissue remodelling-associated conditions
11/03/2009CA2228763C Brewing products and their methods for production
11/03/2009CA2205379C Yeast-based delivery vehicles
11/03/2009CA2181548C Zinc finger protein derivatives and methods therefor
11/03/2009CA2155813C Agents and a method of chromosome preparation using protein phosphatase inhibitors induced premature chromosome condensation
11/03/2009CA2118243C Methods and compositions for monitoring cellular processing of .beta.-amyloid precursor protein
11/01/2009CA2629408A1 Induction balance sensor
10/2009
10/30/2009CA2665054A1 Immunodiagnostic test apparatus having at least one imager to provide advance agglutination evaluations during centrifugation cycle
10/29/2009WO2009132353A2 Differential diagnosis of prostate cancer and benign prostate disease
10/29/2009WO2009132308A2 Methods of identifying agents that promote axonal development
10/29/2009WO2009132271A2 Risk stratification of genetic disease using scoring of amino acid residue conservation in protein families
10/29/2009WO2009132251A2 Methods and compositions comprising anti-idiotypic antibodies to anti-mmp-14 antibodies
10/29/2009WO2009132217A1 Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
10/29/2009WO2009132132A2 Prediction of an individual's risk of developing rheumatoid arthritis
10/29/2009WO2009132130A2 Methods of identifying anti-inflammatory compounds
10/29/2009WO2009132081A2 Monoclonal antibody-based targeting of folate receptors
10/29/2009WO2009132058A2 Levels of bcma protein expression on b cells and use in diagnostic methods
10/29/2009WO2009132028A1 Array structures for nucleic acid detection
10/29/2009WO2009131998A1 Acetaminophen-protein adduct assay device and method
10/29/2009WO2009131989A2 Methods for measuring changes in optical properties of wound tissue and correlating near infrared absorption (fnir) and diffuse reflectance spectroscopy scattering (drs) with tissue neovascularization and collagen concentration to determine whether wound is healing
10/29/2009WO2009131971A2 System and method for testing heat exchange system for heat exchange catheter
10/29/2009WO2009131964A2 Method of detecting calcifying nanoparticles and susceptibility to calcifying nanoparticle formation
10/29/2009WO2009131963A2 Method and kit for assessing the suitability of erythrocytes for transfusion
10/29/2009WO2009131909A2 Recombinant deamidated gliadin antigen
10/29/2009WO2009131891A1 Preparation of sensors on oligo-or poly (ethylene glycol) films on silicon surfaces
10/29/2009WO2009131852A1 Pancreatic beta-cell mass biomarker
10/29/2009WO2009131837A2 Systems, methods and compositions for optical stimulation of target cells
10/29/2009WO2009131686A2 Biochips and related automated analyzers and methods
10/29/2009WO2009131665A1 Borrelia burgdorferi cell envelope protein array
10/29/2009WO2009131645A2 Methods and apparatus for segregation of particles
10/29/2009WO2009131620A1 High-speed molecular analyzer system and method
10/29/2009WO2009131572A1 Structure of tim family members
10/29/2009WO2009131536A1 Molecular assebly comprising gold and a linker for detection of (bio) chemical entities
10/29/2009WO2009131487A1 Method for producing operational standards of serums containing hepatitis c virus antibodies
10/29/2009WO2009131422A2 SCREENING METHOD FOR THERAPEUTIC AGENTS FOR NEUROLOGICAL DISORDERS USING GABA B RECEPTOR AND PROTEIN KINASE A-α
10/29/2009WO2009131365A2 Cst1, dcc1, ifitm1 or melk as markers for diagnosing stomach cancer
10/29/2009WO2009131194A1 Apparatus, kit and method for detection of cholinesterase-inhibiting substance
10/29/2009WO2009130797A1 Probe set for determining abo blood type
10/29/2009WO2009130709A2 A non-recombinant membrane antigen, a diagnostic kit thereof and process for detection of visceral leishmaniasis and pkdl
10/29/2009WO2009130659A2 Plasma membrane vesicles and methods of making and using same
10/29/2009WO2009130649A2 Plasma membrane vesicles and methods of making and using same
10/29/2009WO2009130646A1 Plasmonic biosensor
10/29/2009WO2009130612A2 Prion epitopes and methods of use thereof
10/29/2009WO2009130580A1 Apparatus and method for dating a body sample
10/29/2009WO2009130505A1 Diagnosis and/or prognosis of renal dysfunction
10/29/2009WO2009130471A2 Electrochemical assay
10/29/2009WO2009130420A2 Receptacle for collecting mixed semen, referred to as “polysemen”
10/29/2009WO2009130330A1 Marker for determining biological ageing
10/29/2009WO2009130255A1 Method for determining the ignitability of a fuel
10/29/2009WO2009130254A1 Method for characterising the knock-resistance of fuels
10/29/2009WO2009130241A1 Spintronic magnetic nanoparticle sensors with an active area located on a magnetic domain wall
10/29/2009WO2009130214A1 Instrumentation and analytical techniques suitable for broadband acoustic resonance dissolution spectroscopy
10/29/2009WO2009130195A1 Testing system
10/29/2009WO2009130176A1 Antiviral Therapy
10/29/2009WO2009129773A1 Test device for examining an internal body fluid and packaging thereto
10/29/2009WO2009129693A1 Probes, liquidchip-based products, and methods for detection of egfr gene mutation
10/29/2009WO2009129628A1 Integrated shear-vertical surface acoustic wave and surface plasmon resonance sensing device and method.
10/29/2009WO2009129569A1 An assay to detect a gynecological condition
10/29/2009WO2009111485A3 Infection mediated foam dissolution rate measurement
10/29/2009WO2009108905A3 Fluorescence polarization herg assay
10/29/2009WO2009105662A9 Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (pepst) and exciton-plasmon enhanced phototherapy (epep)
10/29/2009WO2009102789A3 Use of rxr agonists for the treatment of osteroarthritis
10/29/2009WO2009101291A3 System for monitoring a gas storage formation
10/29/2009WO2009100442A3 Methods for detecting molecule-molecule interactions with a single detection channel
10/29/2009WO2009100284A3 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects
10/29/2009WO2009099561A3 Urinary ca125 peptides as biomarkers of ovarian cancer
10/29/2009WO2009098450A3 Methods and compositions
10/29/2009WO2009097119A3 Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity
10/29/2009WO2009093840A3 Method and apparatus for estimating features of target materials by using kinetic change information
10/29/2009WO2009088297A3 Sensor and detection device for use of the sensor
10/29/2009WO2009073141A3 Nogo receptor binding small molecules to promote axonal growth
10/29/2009WO2009043355A3 SYSTEMIC PRO-HEMOSTATIC EFFECT OF SYMPATHICOMIMETICS WITH AGONISTIC EFFECTS ON α-ADRENERGIC AND/OR β-ADRENERGIC RECEPTORS OF THE SYMPATHETIC NERVOUS SYSTEM, RELATED TO IMPROVED CLOT STRENGTH
10/29/2009WO2009021121A4 Identification and characterization of hcv replicon variants with reduced susceptibility to a combination of polymerase and protease inhibitors, and methods related thereto
10/29/2009WO2009009173A3 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases
10/29/2009WO2007141581A8 A method for sensing a chemical
10/29/2009WO2002048386A3 Protein-protein interactions
10/29/2009US20090271164 Predicting long-term efficacy of a compound in the treatment of psoriasis
10/29/2009US20090271162 Crystal structure beta2 adrenoreceptor
10/29/2009US20090271122 Methods and systems for monitoring and modifying a combination treatment
10/29/2009US20090271121 Methods and systems for detecting a bioactive agent effect
10/29/2009US20090271119 Pertioneal Membrane Function Test Method, Peritoneal Membrane Function Test Apparatus and Peritoneal Membrane Function Test Program
10/29/2009US20090271010 Combination treatment alteration methods and systems
10/29/2009US20090270704 Patches, systems, and methods for non-invasive glucose measurement
10/29/2009US20090270697 in vivo ketone monitoring; disposable
10/29/2009US20090270599 In situ heat induced antigen recovery and staining method
10/29/2009US20090270597 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex
10/29/2009US20090270592 Purified TNFR preparations
10/29/2009US20090270482 Analysis of methylated nucleic acid
10/29/2009US20090270327 Lepidopteran-Active Bacillus Thuringiensis Delta-Endotoxin Compositions and Methods of Use
10/29/2009US20090270317 Pharmaceutical compositions comprising bioelastomer fusion proteins
10/29/2009US20090270316 Her-2 binding antagonists
10/29/2009US20090270314 Polypeptide having anti-angiogenic activity
10/29/2009US20090270269 Nano-scale fluoro-biosensors exhibiting a low false alarm rate for rapid detection of biological contaminants
10/29/2009US20090270268 Methods for Obtaining Immortalized Antibody Secreting Cells
10/29/2009US20090270267 Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
10/29/2009US20090270265 Molecular Characteristics of Non-Small Cell Lung Cancer
10/29/2009US20090269859 Mobile Bead Configuration Immunoaffinity Column and Methods of Use
10/29/2009US20090269858 Method of determining the concentration of an analyte using analyte sensor molecules coupled to a porous membrane
1 ... 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 ... 3937